
Grove Secures $4.9 Million to Transform Clinical Trials with Agentic AI
Grove AI, a next-generation clinical trial management and intelligence company, today announced a $4.9 million seed fundraise led by A*, with participation from Afore Capital,
Grove AI, a next-generation clinical trial management and intelligence company, today announced a $4.9 million seed fundraise led by A*, with participation from Afore Capital,
Fuel up with free Health Tech Insights